Invention Grant
- Patent Title: Anti-CXCL13 antibodies and methods of using the same
-
Application No.: US13820278Application Date: 2011-09-01
-
Publication No.: US09963504B2Publication Date: 2018-05-08
- Inventor: Ekaterina Klimatcheva , Mark Paris , Ernest S. Smith
- Applicant: Ekaterina Klimatcheva , Mark Paris , Ernest S. Smith
- Applicant Address: US NY Rochester
- Assignee: Vaccinex, Inc.
- Current Assignee: Vaccinex, Inc.
- Current Assignee Address: US NY Rochester
- Agency: Fisher Broyles LLP
- International Application: PCT/US2011/050177 WO 20110901
- International Announcement: WO2012/031099 WO 20120308
- Main IPC: C07K16/24
- IPC: C07K16/24 ; A61K39/00
Abstract:
Compositions and methods are provided for treating diseases associated with CXCL13 expression, including certain autoimmune diseases, inflammatory diseases, and cancers. In particular, anti-CXCL13 monoclonal antibodies have been developed to neutralize CXCL13.
Public/Granted literature
- US20150050287A9 ANTI-CXCL13 ANTIBODIES AND METHODS OF USING THE SAME Public/Granted day:2015-02-19
Information query
